Suchergebnisse - "Mikus, Gerd"

PubPharm (16)

1

Pharmacoenhancement of Low Crizotinib Plasma Concentrations in Patients with Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer using the CYP3A Inhibitor Cobicistat

enthalten in: Clinical and translational science | 2021

von Hohmann, N. | Bozorgmehr, F. | Christopoulos, P. | +5

2

Composite midazolam and 1'-OH midazolam population pharmacokinetic model for constitutive, inhibited and induced CYP3A activity

enthalten in: Journal of pharmacokinetics and pharmacodynamics | 2020

von Wiebe, S. | Meid, A. | Mikus, G.

3

Proposal of a Safe and Effective Study Design for CYP3A-Mediated Drug-Drug Interactions

enthalten in: Journal of clinical pharmacology | 2020

von Rohr, B. | Mikus, G.

4

Microdosed Cocktail of Three Oral Factor Xa Inhibitors to Evaluate Drug-Drug Interactions with Potential Perpetrator Drugs

enthalten in: Clinical pharmacokinetics | 2019

von Mikus, G. | Foerster, K. | Schaumaeker, M. | +3

5

Novel insights into the complex pharmacokinetics of voriconazole : a review of its metabolism

enthalten in: Drug metabolism reviews | 2019

von Schulz, J. | Kluwe, F. | Mikus, G. | +2

6

Autoinhibitory properties of the parent but not of the N-oxide metabolite contribute to infusion rate-dependent voriconazole pharmacokinetics

enthalten in: British journal of clinical pharmacology | 2017

von Hohmann, N. | Kreuter, R. | Blank, A. | +4

7

Dose-Dependent Bioavailability and CYP3A Inhibition Contribute to Non-Linear Pharmacokinetics of Voriconazole

enthalten in: Clinical pharmacokinetics | 2016

von Hohmann, N. | Kocheise, F. | Carls, A. | +4

8

No Increased Risk of Ketoconazole Toxicity in Drug-Drug Interaction Studies

enthalten in: Journal of clinical pharmacology | 2016

von Outeiro, N. | Hohmann, N. | Mikus, G.

9

Pharmacokinetic interaction of intravenous fentanyl with ketoconazole

enthalten in: Journal of clinical pharmacology | 2015

von Ziesenitz, V. | König, S. | Mahlke, N. | +3

10

Systemic exposure of topical erythromycin in comparison to oral administration and the effect on cytochrome P450 3A4 activity

enthalten in: British journal of clinical pharmacology | 2014

von Carls, A. | Jedamzik, J. | Witt, L. | +3